GALD.SW

Healthcare Drug Manufacturers - Specialty & Generic

Galderma Group AG

CHF 162.40

+2.05 +1.28% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 10:21 AM ET	162.40

Key Stats

Market Cap

37.87B

Avg Volume

530,121

P/E (TTM)

56.00

EPS

CHF 2.90

52W High

CHF 188.25

52W Low

CHF 134.70

Div. Yield

0.3%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

29.10

P/B Ratio

5.51

P/S Ratio

6.39

EV/EBITDA

28.37

EV/Revenue

6.64

PEG Ratio

1.16

Margins

Gross Margin 69.4%

Operating Margin 20.2%

Net Margin 14.6%

EBITDA Margin 23.4%

Growth & Returns

Revenue Growth (YoY)

27.7%

Earnings Growth (YoY)

130.7%

Earnings Growth (QoQ)

128.9%

Return on Equity

10.8%

Return on Assets

5.4%

Liquidity & Leverage

Current Ratio

1.24

Quick Ratio

0.90

Debt / Equity

0.33

Total Cash

839.00M

Total Debt

2.72B

About

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.